CGABL vs CLOV · rev $5.43B vs rev $1.37B
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) common stock listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported CGABL revenue for 2024-12-31 was $5.43B. Net income was $1.09B. Revenue was up 83.1% from 2023-12-31 to 2024-12-31. CGABL currently screens at market cap $16.14B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
CGABL currently screens at market cap $16.14B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the CGABL and CLOV stock pages for the full models.
Not investment advice.